Products - Endometrial cancers | Topic | NICE

Showing 3 products

Date | Title

Status: Awaiting developmentRemove ‘Status: Awaiting development’ filter

Pembrolizumab with chemotherapy for adjuvant treatment of newly diagnosed high-risk endometrial cancer after surgery with curative intent [TSID11808]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Technologies to improve detection of endometrial cancer
Status:
Awaiting development
Programme:
Health technology evaluation
Expected publication date:
TBC
Dostarlimab for treating primary advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency when systemic treatment is suitable [ID6660]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC